• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于估计模拟序列进展饱和度的计算方法。

Computational method for estimating progression saturation of analog series.

作者信息

Kunimoto Ryo, Miyao Tomoyuki, Bajorath Jürgen

机构信息

Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität Dahlmannstr. 2 D-53113 Bonn Germany

出版信息

RSC Adv. 2018 Jan 31;8(10):5484-5492. doi: 10.1039/c7ra13748f. eCollection 2018 Jan 29.

DOI:10.1039/c7ra13748f
PMID:35542404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9078142/
Abstract

In lead optimization, it is difficult to estimate when an analog series might be saturated and synthesis of additional compounds would be unlikely to yield further progress. Rather than terminating a series, one often continues to generate analogs hoping to reach the final optimization goal, even if obstacles that are faced ultimately prove to be unsurmountable. Clearly, methodologies to better understand series progression and saturation are highly desirable. However, only a few approaches are currently available to monitor series progression and aid in decision making. Herein, we introduce a new computational method to assess progression saturation of an analog series by relating the properties of existing compounds to those of synthetic candidates and comparing their distributions in chemical space. The neighborhoods of analogs are analyzed and the distance relationships between existing and candidate compounds quantified. An intuitive dual scoring scheme makes it possible to characterize analog series and their degree of progression saturation.

摘要

在先导化合物优化过程中,很难估计一个类似物系列何时可能达到饱和,以及合成更多化合物是否不太可能带来进一步进展。与其终止一个系列,人们通常会继续生成类似物,希望达到最终的优化目标,即使最终面临的障碍被证明是无法克服的。显然,非常需要能够更好地理解系列进展和饱和情况的方法。然而,目前只有少数方法可用于监测系列进展并辅助决策。在此,我们介绍一种新的计算方法,通过将现有化合物的性质与合成候选物的性质相关联,并比较它们在化学空间中的分布,来评估类似物系列的进展饱和度。分析类似物的邻域,并量化现有化合物与候选化合物之间的距离关系。一种直观的双重评分方案使得能够表征类似物系列及其进展饱和程度。

相似文献

1
Computational method for estimating progression saturation of analog series.用于估计模拟序列进展饱和度的计算方法。
RSC Adv. 2018 Jan 31;8(10):5484-5492. doi: 10.1039/c7ra13748f. eCollection 2018 Jan 29.
2
From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.从 SARS 诊断到化合物设计:化合物优化监测器 (COMO) 方法的开发历程。
Mol Inform. 2020 Dec;39(12):e2000046. doi: 10.1002/minf.202000046. Epub 2020 Apr 24.
3
Computational Method to Evaluate Progress in Lead Optimization.计算方法评估先导化合物优化进展。
J Med Chem. 2018 Dec 13;61(23):10895-10900. doi: 10.1021/acs.jmedchem.8b01626. Epub 2018 Nov 30.
4
Computational Assessment of Chemical Saturation of Analogue Series under Varying Conditions.不同条件下类似物系列化学饱和度的计算评估
ACS Omega. 2018 Nov 30;3(11):15799-15808. doi: 10.1021/acsomega.8b02087. Epub 2018 Nov 20.
5
DeepCOMO: from structure-activity relationship diagnostics to generative molecular design using the compound optimization monitor methodology.DeepCOMO:利用化合物优化监测方法从结构-活性关系诊断到生成分子设计。
J Comput Aided Mol Des. 2020 Dec;34(12):1207-1218. doi: 10.1007/s10822-020-00349-3. Epub 2020 Oct 5.
6
Integrating computational lead optimization diagnostics with analog design and candidate selection.将计算先导优化诊断与模拟设计及候选物选择相结合。
Future Sci OA. 2020 Jan 24;6(3):FSO451. doi: 10.2144/fsoa-2019-0131.
7
Exploring structure-promiscuity relationships using dual-site promiscuity cliffs and corresponding single-site analogs.利用双位点混杂悬崖和相应的单点类似物探索结构混杂关系。
Bioorg Med Chem. 2020 Jan 1;28(1):115238. doi: 10.1016/j.bmc.2019.115238. Epub 2019 Nov 30.
8
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification头部损伤的转化代谢组学:基于体外核磁共振波谱的代谢物定量分析探索脑代谢功能障碍
9
Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.用于系统鉴定模拟系列以及代表系列的关键化合物及其生物活性谱的计算方法。
J Med Chem. 2016 Aug 25;59(16):7667-76. doi: 10.1021/acs.jmedchem.6b00906. Epub 2016 Aug 8.
10
AnalogExplorer2 - Stereochemistry sensitive graphical analysis of large analog series.AnalogExplorer2 - 大型类似物系列的立体化学敏感性图形分析
F1000Res. 2015 Oct 9;4. doi: 10.12688/f1000research.7146.1. eCollection 2015.

引用本文的文献

1
Automatic Identification of Analogue Series from Large Compound Data Sets: Methods and Applications.自动识别大型化合物数据集的类似物系列:方法与应用。
Molecules. 2021 Aug 31;26(17):5291. doi: 10.3390/molecules26175291.
2
DeepCOMO: from structure-activity relationship diagnostics to generative molecular design using the compound optimization monitor methodology.DeepCOMO:利用化合物优化监测方法从结构-活性关系诊断到生成分子设计。
J Comput Aided Mol Des. 2020 Dec;34(12):1207-1218. doi: 10.1007/s10822-020-00349-3. Epub 2020 Oct 5.
3
From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.

本文引用的文献

1
PubChem BioAssay: 2017 update.《PubChem生物测定:2017年更新》
Nucleic Acids Res. 2017 Jan 4;45(D1):D955-D963. doi: 10.1093/nar/gkw1118. Epub 2016 Nov 29.
2
Compound Data Mining for Drug Discovery.用于药物发现的复合数据挖掘
Methods Mol Biol. 2017;1526:247-256. doi: 10.1007/978-1-4939-6613-4_14.
3
Computational Method for the Systematic Identification of Analog Series and Key Compounds Representing Series and Their Biological Activity Profiles.用于系统鉴定模拟系列以及代表系列的关键化合物及其生物活性谱的计算方法。
从 SARS 诊断到化合物设计:化合物优化监测器 (COMO) 方法的开发历程。
Mol Inform. 2020 Dec;39(12):e2000046. doi: 10.1002/minf.202000046. Epub 2020 Apr 24.
4
Finding Constellations in Chemical Space Through Core Analysis.通过核心分析在化学空间中寻找星座。
Front Chem. 2019 Jul 16;7:510. doi: 10.3389/fchem.2019.00510. eCollection 2019.
5
Computational Assessment of Chemical Saturation of Analogue Series under Varying Conditions.不同条件下类似物系列化学饱和度的计算评估
ACS Omega. 2018 Nov 30;3(11):15799-15808. doi: 10.1021/acsomega.8b02087. Epub 2018 Nov 20.
J Med Chem. 2016 Aug 25;59(16):7667-76. doi: 10.1021/acs.jmedchem.6b00906. Epub 2016 Aug 8.
4
Monitoring the Progression of Structure-Activity Relationship Information during Lead Optimization.在先导化合物优化过程中监测构效关系信息的进展
J Med Chem. 2016 May 12;59(9):4235-44. doi: 10.1021/acs.jmedchem.5b01428. Epub 2015 Nov 16.
5
Quantifying, Visualizing, and Monitoring Lead Optimization.量化、可视化及监测先导物优化
J Med Chem. 2016 May 12;59(9):4189-201. doi: 10.1021/acs.jmedchem.5b00948. Epub 2015 Aug 21.
6
Lead optimization attrition analysis (LOAA): a novel and general methodology for medicinal chemistry.先导化合物优化损耗分析(LOAA):一种用于药物化学的新颖通用方法。
Drug Discov Today. 2015 Aug;20(8):978-87. doi: 10.1016/j.drudis.2015.03.010. Epub 2015 Mar 24.
7
Advances in multiparameter optimization methods for de novo drug design.从头药物设计中多参数优化方法的进展。
Expert Opin Drug Discov. 2014 Jul;9(7):803-17. doi: 10.1517/17460441.2014.913565. Epub 2014 May 3.
8
QSAR modeling: where have you been? Where are you going to?定量构效关系模型:你从何处来?你将往何处去?
J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6.
9
Molecular similarity in medicinal chemistry.药物化学中的分子相似性。
J Med Chem. 2014 Apr 24;57(8):3186-204. doi: 10.1021/jm401411z. Epub 2013 Nov 11.
10
ChEMBL: a large-scale bioactivity database for drug discovery.ChEMBL:用于药物发现的大型生物活性数据库。
Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7. doi: 10.1093/nar/gkr777. Epub 2011 Sep 23.